<table id="table10" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 10: Drug Interactions: Pharmacokinetic Parameters for Darunavir in the Presence of Co-administered Drugs</caption>
<col align="left" valign="top" width="15%"></col>
<col align="center" valign="top" width="15%"></col>
<col align="center" valign="top" width="15%"></col>
<col align="center" valign="top" width="5%"></col>
<col align="center" valign="top" width="5%"></col>
<col align="center" valign="top" width="15%"></col>
<col align="center" valign="top" width="15%"></col>
<col align="center" valign="top" width="15%"></col>
<thead>
<tr stylecode="Botrule">
<th rowspan="2" stylecode="Lrule Rrule" valign="bottom">Co-Administered Drug</th>
<th colspan="2" stylecode="Rrule" valign="bottom">Dose/Schedule</th>
<th rowspan="2" stylecode="Rrule" valign="bottom">N</th>
<th rowspan="2" stylecode="Rrule" valign="bottom">PK</th>
<th colspan="3" stylecode="Rrule" valign="bottom">LS Mean Ratio (90% CI) of <content stylecode="underline">Darunavir</content> Pharmacokinetic Parameters With/Without Co-administered Drug<br/> No Effect =1.00</th>
</tr>
<tr>
<th align="center" stylecode="Rrule Botrule" valign="bottom">Co-Administered Drug</th>
<th stylecode="Rrule Botrule" valign="bottom">Darunavir/<br/>ritonavir</th>
<th stylecode="Rrule Botrule" valign="bottom">C<sub>max</sub>
</th>
<th stylecode="Rrule Botrule" valign="bottom">AUC</th>
<th stylecode="Rrule Botrule" valign="bottom">C<sub>min</sub>
</th>
</tr>
</thead>
<tfoot>
<tr>
<td align="left" colspan="8">N = number of subjects with data; - = no information available.</td>
</tr>
</tfoot>
<tbody>
<tr stylecode="Botrule">
<td colspan="8" stylecode="Lrule Rrule">
<content stylecode="bold">Co-Administration With Other Protease Inhibitors</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Atazanavir</td>
<td stylecode="Rrule">300 mg q.d.<footnote>q.d. = once daily</footnote>
</td>
<td stylecode="Rrule">400/100 mg b.i.d. <footnote>b.i.d. = twice daily</footnote>
</td>
<td stylecode="Rrule">13</td>
<td stylecode="Rrule">↔</td>
<td stylecode="Rrule">1.02<br/>(0.96-1.09)</td>
<td stylecode="Rrule">1.03<br/>(0.94-1.12)</td>
<td stylecode="Rrule">1.01<br/>(0.88-1.16)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Indinavir</td>
<td stylecode="Rrule">800 mg b.i.d.</td>
<td stylecode="Rrule">400/100 mg b.i.d.</td>
<td stylecode="Rrule">9</td>
<td stylecode="Rrule">↑</td>
<td stylecode="Rrule">1.11<br/>(0.98-1.26)</td>
<td stylecode="Rrule">1.24<br/>(1.09-1.42)</td>
<td stylecode="Rrule">1.44<br/>(1.13-1.82)</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Lopinavir/ Ritonavir</td>
<td stylecode="Rrule">400/100 mg b.i.d.</td>
<td stylecode="Rrule">1200/100 mg b.i.d.<footnote id="t8ft3">The pharmacokinetic parameters of darunavir in this study were compared with the pharmacokinetic parameters following administration of darunavir/ritonavir 600/100 mg b.i.d.</footnote>
</td>
<td stylecode="Rrule">14</td>
<td stylecode="Rrule">↓</td>
<td stylecode="Rrule">0.79<br/>(0.67-0.92)</td>
<td stylecode="Rrule">0.62<br/>(0.53-0.73)</td>
<td stylecode="Rrule">0.49<br/>(0.39-0.63)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule"></td>
<td stylecode="Rrule">533/133.3 mg b.i.d.</td>
<td stylecode="Rrule">1200 mg b.i.d.<footnoteref idref="t8ft3"></footnoteref>
</td>
<td stylecode="Rrule">15</td>
<td stylecode="Rrule">↓</td>
<td stylecode="Rrule">0.79<br/>(0.64-0.97)</td>
<td stylecode="Rrule">0.59<br/>(0.50-0.70)</td>
<td stylecode="Rrule">0.45<br/>(0.38-0.52)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Saquinavir hard gel capsule<br/>
</td>
<td stylecode="Rrule">1000 mg b.i.d.</td>
<td stylecode="Rrule">400/100 mg b.i.d.</td>
<td stylecode="Rrule">14</td>
<td stylecode="Rrule">↓</td>
<td stylecode="Rrule">0.83<br/>(0.75-0.92)</td>
<td stylecode="Rrule">0.74<br/>(0.63-0.86)</td>
<td stylecode="Rrule">0.58<br/>(0.47-0.72)</td>
</tr>
<tr stylecode="Botrule">
<td colspan="8" stylecode="Lrule Rrule">
<content stylecode="bold">Co-Administration With Other Antiretrovirals</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Didanosine</td>
<td stylecode="Rrule">400 mg q.d.</td>
<td stylecode="Rrule">600/100 mg b.i.d.</td>
<td stylecode="Rrule">17</td>
<td stylecode="Rrule">↔</td>
<td stylecode="Rrule">0.93<br/>(0.86-1.00)</td>
<td stylecode="Rrule">1.01<br/>(0.95-1.07)</td>
<td stylecode="Rrule">1.07<br/>(0.95-1.21)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Efavirenz</td>
<td stylecode="Rrule">600 mg q.d.</td>
<td stylecode="Rrule">300/100 mg b.i.d.</td>
<td stylecode="Rrule">12</td>
<td stylecode="Rrule">↓</td>
<td stylecode="Rrule">0.85<br/>(0.72-1.00)</td>
<td stylecode="Rrule">0.87<br/>(0.75-1.01)</td>
<td stylecode="Rrule">0.69<br/>(0.54-0.87)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Etravirine</td>
<td stylecode="Rrule">200 mg b.i.d.</td>
<td stylecode="Rrule">600/100 mg b.i.d.</td>
<td stylecode="Rrule">15</td>
<td stylecode="Rrule">↔</td>
<td stylecode="Rrule">1.11<br/>(1.01-1.22)</td>
<td stylecode="Rrule">1.15<br/>(1.05-1.26)</td>
<td stylecode="Rrule">1.02<br/>(0.90-1.17)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Nevirapine</td>
<td stylecode="Rrule">200 mg b.i.d.</td>
<td stylecode="Rrule">400/100 mg b.i.d.</td>
<td stylecode="Rrule">8</td>
<td stylecode="Rrule">↑</td>
<td stylecode="Rrule">1.40 <footnote id="t8ft4">Ratio based on between-study comparison.</footnote>
<br/>(1.14-1.73)</td>
<td stylecode="Rrule">1.24 <footnoteref idref="t8ft4"></footnoteref>
<br/>(0.97-1.57)</td>
<td stylecode="Rrule">1.02 <footnoteref idref="t8ft4"></footnoteref>
<br/>(0.79-1.32)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Tenofovir Disoproxil Fumarate</td>
<td stylecode="Rrule">300 mg q.d.</td>
<td stylecode="Rrule">300/100 mg b.i.d.</td>
<td stylecode="Rrule">12</td>
<td stylecode="Rrule">↑</td>
<td stylecode="Rrule">1.16<br/>(0.94-1.42)</td>
<td stylecode="Rrule">1.21<br/>(0.95-1.54)</td>
<td stylecode="Rrule">1.24<br/>(0.90-1.69)</td>
</tr>
<tr stylecode="Botrule">
<td colspan="8" stylecode="Lrule Rrule">
<content stylecode="bold">Co-Administration With Other Drugs</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Carbamazepine</td>
<td stylecode="Rrule">200 mg b.i.d.</td>
<td stylecode="Rrule">600/100 mg b.i.d.</td>
<td stylecode="Rrule">16</td>
<td stylecode="Rrule">↔</td>
<td stylecode="Rrule">1.04<br/>(0.93-1.16)</td>
<td stylecode="Rrule">0.99<br/>(0.90-1.08)</td>
<td stylecode="Rrule">0.85<br/>(0.73-1.00)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Clarithromycin</td>
<td stylecode="Rrule">500 mg b.i.d.</td>
<td stylecode="Rrule">400/100 mg b.i.d.</td>
<td stylecode="Rrule">17</td>
<td stylecode="Rrule">↔</td>
<td stylecode="Rrule">0.83<br/>(0.72-0.96)</td>
<td stylecode="Rrule">0.87<br/>(0.75-1.01)</td>
<td stylecode="Rrule">1.01<br/>(0.81-1.26)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Ketoconazole</td>
<td stylecode="Rrule">200 mg b.i.d.</td>
<td stylecode="Rrule">400/100 mg b.i.d.</td>
<td stylecode="Rrule">14</td>
<td stylecode="Rrule">↑</td>
<td stylecode="Rrule">1.21<br/>(1.04-1.40)</td>
<td stylecode="Rrule">1.42<br/>(1.23-1.65)</td>
<td stylecode="Rrule">1.73<br/>(1.39-2.14)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Omeprazole</td>
<td stylecode="Rrule">20 mg q.d.</td>
<td stylecode="Rrule">400/100 mg b.i.d.</td>
<td stylecode="Rrule">16</td>
<td stylecode="Rrule">↔</td>
<td stylecode="Rrule">1.02<br/>(0.95-1.09)</td>
<td stylecode="Rrule">1.04<br/>(0.96-1.13)</td>
<td stylecode="Rrule">1.08<br/>(0.93-1.25)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Paroxetine</td>
<td stylecode="Rrule">20 mg q.d.</td>
<td stylecode="Rrule">400/100 mg b.i.d.</td>
<td stylecode="Rrule">16</td>
<td stylecode="Rrule">↔</td>
<td stylecode="Rrule">0.97<br/>(0.92-1.02)</td>
<td stylecode="Rrule">1.02<br/>(0.95-1.10)</td>
<td stylecode="Rrule">1.07<br/>(0.96-1.19)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Ranitidine</td>
<td stylecode="Rrule">150 mg b.i.d.</td>
<td stylecode="Rrule">400/100 mg b.i.d.</td>
<td stylecode="Rrule">16</td>
<td stylecode="Rrule">↔</td>
<td stylecode="Rrule">0.96<br/>(0.89-1.05)</td>
<td stylecode="Rrule">0.95<br/>(0.90-1.01)</td>
<td stylecode="Rrule">0.94<br/>(0.90-0.99)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Rifabutin</td>
<td stylecode="Rrule">150 mg q.o.d. <footnote>q.o.d. = every other day</footnote>
</td>
<td stylecode="Rrule">600/100 mg b.i.d.</td>
<td stylecode="Rrule">11</td>
<td stylecode="Rrule">↑</td>
<td stylecode="Rrule">1.42<br/>(1.21-1.67)</td>
<td stylecode="Rrule">1.57<br/>(1.28-1.93)</td>
<td stylecode="Rrule">1.75<br/>(1.28-2.37)</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Sertraline</td>
<td stylecode="Rrule">50 mg q.d.</td>
<td stylecode="Rrule">400/100 mg b.i.d.</td>
<td stylecode="Rrule">13</td>
<td stylecode="Rrule">↔</td>
<td stylecode="Rrule">1.01<br/>(0.89-1.14)</td>
<td stylecode="Rrule">0.98<br/>(0.84-1.14)</td>
<td stylecode="Rrule">0.94<br/>(0.76-1.16)</td>
</tr>
</tbody>
</table>